Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cairns, P.
Right arrow Articles by Sidransky, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cairns, P.
Right arrow Articles by Sidransky, D.
Clinical Cancer Research Vol. 7, 2727-2730, September 2001
© 2001 American Association for Cancer Research

Regular Articles

Molecular Detection of Prostate Cancer in Urine by GSTP1 Hypermethylation1

Paul Cairns, Manel Esteller, James G. Herman, Mark Schoenberg, Carmen Jeronimo, Montserrat Sanchez-Cespedes, Nan-Haw Chow, Marc Grasso, Li Wu, William B. Westra and David Sidransky2

Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [P. C.], and Tumor Biology, Oncology Center [M. E., J. G. H., D. S.], Departments of Urology [M. S., D. S.], Otolaryngology, Head and Neck Surgery, Division of Head and Neck Cancer Research [C. J., M. S-C., N-H. C., M. G., L. W., D. S.], and Pathology [W. B. W., D. S.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2195

Novel approaches for the early detection and management of prostate cancer are urgently needed. Clonal genetic alterations have been used as targets for the detection of neoplastic cells in bodily fluids from many cancer types. A similar strategy for molecular diagnosis of prostate cancer requires a common and/or early genetic alteration as a specific target for neoplastic prostate cells. Hypermethylation of regulatory sequences at the glutathione S-transferase pi (GSTP1) gene locus is found in the majority (>90%) of primary prostate carcinomas, but not in normal prostatic tissue or other normal tissues. We hypothesized that urine from prostate cancer patients might contain shed neoplastic cells or debris amenable to DNA analysis. Matched specimens of primary tumor, peripheral blood lymphocytes (normal control), and simple voided urine were collected from 28 patients with prostate cancer of a clinical stage amenable to cure. Genomic DNA was isolated from the samples, and the methylation status of GSTP1 was examined in a blinded manner using methylation-specific PCR. Decoding of the results revealed that 22 of 28 (79%) prostate tumors were positive for GSTP1 methylation. In 6 of 22 (27%) cases, the corresponding urine-sediment DNA was positive for GSTP1 methylation, indicating the presence of neoplastic DNA in the urine. Furthermore, there was no case where urine-sediment DNA harbored methylation when the corresponding tumor was negative. Although we only detected GSTP1 methylation in under one-third of voided urine samples, we have demonstrated that molecular diagnosis of prostate neoplasia in urine is feasible. Larger studies focusing on carcinoma size, location in the prostate, and urine collection techniques, as well as more sensitive technology, may lead to the useful application of GSTP1 hypermethylation in prostate cancer diagnosis and management.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
N. Hokaiwado, F. Takeshita, A. Naiki-Ito, M. Asamoto, T. Ochiya, and T. Shirai
Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells
Carcinogenesis, June 1, 2008; 29(6): 1134 - 1138.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Vener, C. Derecho, J. Baden, H. Wang, Y. Rajpurohit, J. Skelton, J. Mehrotra, S. Varde, D. Chowdary, W. Stallings, et al.
Development of a Multiplexed Urine Assay for Prostate Cancer Diagnosis
Clin. Chem., May 1, 2008; 54(5): 874 - 882.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Esteller
Epigenetics in Cancer
N. Engl. J. Med., March 13, 2008; 358(11): 1148 - 1159.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Henrique, F. R. Ribeiro, D. Fonseca, M. O. Hoque, A. L. Carvalho, V. L. Costa, M. Pinto, J. Oliveira, M. R. Teixeira, D. Sidransky, et al.
High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients
Clin. Cancer Res., October 15, 2007; 13(20): 6122 - 6129.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Kagan, S. Srivastava, P. E. Barker, S. A. Belinsky, and P. Cairns
Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools
Cancer Res., May 15, 2007; 67(10): 4545 - 4549.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Roupret, V. Hupertan, D. R. Yates, J. W.F. Catto, I. Rehman, M. Meuth, S. Ricci, R. Lacave, G. Cancel-Tassin, A. de la Taille, et al.
Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage
Clin. Cancer Res., March 15, 2007; 13(6): 1720 - 1725.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R. Tetzner, D. Dietrich, and J. Distler
Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA
Nucleic Acids Res., January 12, 2007; 35(1): e4 - e4.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Foltz, G.-Y. Ryu, J.-G. Yoon, T. Nelson, J. Fahey, A. Frakes, H. Lee, L. Field, K. Zander, Z. Sibenaller, et al.
Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant Glioma.
Cancer Res., July 1, 2006; 66(13): 6665 - 6674.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. S Perry, R. Foley, K. Woodson, and M. Lawler
The emerging roles of DNA methylation in the clinical management of prostate cancer.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 357 - 377.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Enokida, H. Shiina, S. Urakami, M. Igawa, T. Ogishima, L.-C. Li, M. Kawahara, M. Nakagawa, C. J. Kane, P. R. Carroll, et al.
Multigene Methylation Analysis for Detection and Staging of Prostate Cancer
Clin. Cancer Res., September 15, 2005; 11(18): 6582 - 6588.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. O. Hoque, E. Rosenbaum, W. H. Westra, M. Xing, P. Ladenson, M. A. Zeiger, D. Sidransky, and C. B. Umbricht
Quantitative Assessment of Promoter Methylation Profiles in Thyroid Neoplasms
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4011 - 4018.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K. Miyamoto and T. Ushijima
Diagnostic and Therapeutic Applications of Epigenetics
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. L. Russo, A. Thiagalingam, H. Pan, J. Califano, K.-h. Cheng, J. F. Ponte, D. Chinnappan, P. Nemani, D. Sidransky, and S. Thiagalingam
Differential DNA Hypermethylation of Critical Genes Mediates the Stage-Specific Tobacco Smoke-Induced Neoplastic Progression of Lung Cancer
Clin. Cancer Res., April 1, 2005; 11(7): 2466 - 2470.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L.-C. Li, P. R. Carroll, and R. Dahiya
Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment
J Natl Cancer Inst, January 19, 2005; 97(2): 103 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. I. de Caceres, C. Battagli, M. Esteller, J. G. Herman, E. Dulaimi, M. I. Edelson, C. Bergman, H. Ehya, B. L. Eisenberg, and P. Cairns
Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients
Cancer Res., September 15, 2004; 64(18): 6476 - 6481.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Dulaimi, J. Hillinck, I. I. de Caceres, T. Al-Saleem, and P. Cairns
Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients
Clin. Cancer Res., September 15, 2004; 10(18): 6189 - 6193.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Parrella, M. L. Poeta, A. P. Gallo, M. Prencipe, M. Scintu, A. Apicella, R. Rossiello, G. Liguoro, D. Seripa, C. Gravina, et al.
Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors
Clin. Cancer Res., August 15, 2004; 10(16): 5349 - 5354.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. V. Tricoli, M. Schoenfeldt, and B. A. Conley
Detection of Prostate Cancer and Predicting Progression: Current and Future Diagnostic Markers
Clin. Cancer Res., June 15, 2004; 10(12): 3943 - 3953.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Yegnasubramanian, J. Kowalski, M. L. Gonzalgo, M. Zahurak, S. Piantadosi, P. C. Walsh, G. S. Bova, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson
Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer
Cancer Res., March 15, 2004; 64(6): 1975 - 1986.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Dulaimi, R. G. Uzzo, R. E. Greenberg, T. Al-Saleem, and P. Cairns
Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel
Clin. Cancer Res., March 15, 2004; 10(6): 1887 - 1893.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Krassenstein, E. Sauter, E. Dulaimi, C. Battagli, H. Ehya, A. Klein-Szanto, and P. Cairns
Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation
Clin. Cancer Res., January 1, 2004; 10(1): 28 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Battagli, R. G. Uzzo, E. Dulaimi, I. Ibanez de Caceres, R. Krassenstein, T. Al-Saleem, R. E. Greenberg, and P. Cairns
Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Kidney Cancer Patients
Cancer Res., December 15, 2003; 63(24): 8695 - 8699.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. G. Herman and S. B. Baylin
Gene Silencing in Cancer in Association with Promoter Hypermethylation
N. Engl. J. Med., November 20, 2003; 349(21): 2042 - 2054.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. V. Harden, H. Sanderson, S. N. Goodman, A. A. W. Partin, P. C. Walsh, J. I. Epstein, and D. Sidransky
Quantitative GSTP1 Methylation and the Detection of Prostate Adenocarcinoma in Sextant Biopsies
J Natl Cancer Inst, November 5, 2003; 95(21): 1634 - 1637.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Nakayama, C. J. Bennett, J. L. Hicks, J. I. Epstein, E. A. Platz, W. G. Nelson, and A. M. De Marzo
Hypermethylation of the Human Glutathione S-Transferase-{pi} Gene (GSTP1) CpG Island Is Present in a Subset of Proliferative Inflammatory Atrophy Lesions but Not in Normal or Hyperplastic Epithelium of the Prostate: A Detailed Study Using Laser-Capture Microdissection
Am. J. Pathol., September 1, 2003; 163(3): 923 - 933.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. L. Gonzalgo, C. P. Pavlovich, S. M. Lee, and W. G. Nelson
Prostate Cancer Detection by GSTP1 Methylation Analysis of Postbiopsy Urine Specimens
Clin. Cancer Res., July 1, 2003; 9(7): 2673 - 2677.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. Tost, P. Schatz, M. Schuster, K. Berlin, and I. G. Gut
Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry
Nucleic Acids Res., May 1, 2003; 31(9): e50 - e50.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C Jeronimo, R Henrique, P F Campos, J Oliveira, O L Caballero, C Lopes, and D Sidransky
Endothelin B receptor gene hypermethylation in prostate adenocarcinoma
J. Clin. Pathol., January 1, 2003; 56(1): 52 - 55.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Rathi, A. K. Virmani, J. O. Schorge, K. J. Elias, R. Maruyama, J. D. Minna, S. C. Mok, L. Girard, D. A. Fishman, and A. F. Gazdar
Methylation Profiles of Sporadic Ovarian Tumors and nonmalignant Ovaries from High-Risk Women
Clin. Cancer Res., November 1, 2002; 8(11): 3324 - 3331.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Jeronimo, G. Varzim, R. Henrique, J. Oliveira, M. J. Bento, C. Silva, C. Lopes, and D. Sidransky
I105V Polymorphism and Promoter Methylation of the GSTP1 Gene in Prostate Adenocarcinoma
Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 445 - 450.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. W. Y. Chan, L. W. Chan, N. L. S. Tang, J. H. M. Tong, K. W. Lo, T. L. Lee, H. Y. Cheung, W. S. Wong, P. S. F. Chan, F. M. M. Lai, et al.
Hypermethylation of Multiple Genes in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients
Clin. Cancer Res., February 1, 2002; 8(2): 464 - 470.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. Jeronimo, H. Usadel, R. Henrique, J. Oliveira, C. Lopes, W. G. Nelson, and D. Sidransky
Quantitation of GSTP1 Methylation in Non-neoplastic Prostatic Tissue and Organ-Confined Prostate Adenocarcinoma
J Natl Cancer Inst, November 21, 2001; 93(22): 1747 - 1752.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.